These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 38578670)
21. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. Seiffert K; Ding W; Wagner JA; Granstein RD J Invest Dermatol; 2006 May; 126(5):1017-27. PubMed ID: 16410784 [TBL] [Abstract][Full Text] [Related]
22. Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue. Alexander K; Niforatos W; Bianchi B; Burgard EC; Lynch KJ; Kowaluk EA; Jarvis MF; van Biesen T J Pharmacol Exp Ther; 1999 Dec; 291(3):1135-42. PubMed ID: 10565834 [TBL] [Abstract][Full Text] [Related]
24. Recent progress in the structural biology of P2X receptors. Sheng D; Hattori M Proteins; 2022 Oct; 90(10):1779-1785. PubMed ID: 35023590 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists. Jung KY; Cho JH; Lee JS; Kim HJ; Kim YC Bioorg Med Chem; 2013 May; 21(9):2643-50. PubMed ID: 23510563 [TBL] [Abstract][Full Text] [Related]
26. Ion permeation pathway within the internal pore of P2X receptor channels. Tam SW; Huffer K; Li M; Swartz KJ Elife; 2023 Mar; 12():. PubMed ID: 36940138 [TBL] [Abstract][Full Text] [Related]
27. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. Shibuya I; Tanaka K; Hattori Y; Uezono Y; Harayama N; Noguchi J; Ueta Y; Izumi F; Yamashita H J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):351-67. PubMed ID: 9852319 [TBL] [Abstract][Full Text] [Related]
28. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate. Trezise DJ; Kennedy I; Humphrey PP Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652 [TBL] [Abstract][Full Text] [Related]
29. Complexities of measuring antagonist potency at P2X(7) receptor orthologs. Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928 [TBL] [Abstract][Full Text] [Related]
30. Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius. Jin YH; Bailey TW; Li BY; Schild JH; Andresen MC J Neurosci; 2004 May; 24(20):4709-17. PubMed ID: 15152030 [TBL] [Abstract][Full Text] [Related]
31. ATP-gated ion channels assembled from P2X2 receptor subunits in the mouse cochlea. Järlebark LE; Housley GD; Raybould NP; Vlajkovic S; Thorne PR Neuroreport; 2002 Oct; 13(15):1979-84. PubMed ID: 12395104 [TBL] [Abstract][Full Text] [Related]
32. Functional expression of three P2X(2) receptor splice variants from guinea pig cochlea. Chen C; Parker MS; Barnes AP; Deininger P; Bobbin RP J Neurophysiol; 2000 Mar; 83(3):1502-9. PubMed ID: 10712475 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists. Kim YC; Camaioni E; Ziganshin AU; Ji XD; King BF; Wildman SS; Rychkov A; Yoburn J; Kim H; Mohanram A; Harden TK; Boyer JL; Burnstock G; Jacobson KA Drug Dev Res; 1998 Oct; 45(2):52-66. PubMed ID: 22922976 [TBL] [Abstract][Full Text] [Related]